​

Vincerx Pharma (VINC) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

VINC Stock Forecast

Vincerx Pharma (VINC) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $3.00, with a high of $4.00 and a low of $2.00. This represents a 9900.00% increase from the last price of $0.03.

- $1 $2 $3 $4 $5 $6 High: $4 Avg: $3 Low: $2 Last Closed Price: $0.03

VINC Stock Rating

Vincerx Pharma stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 7 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 7 Strong Sell Sell Hold Buy Strong Buy

VINC Price Target Upside V Benchmarks

TypeNameUpside
StockVincerx Pharma9900.00%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.03$0.03$0.03
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 251----1
May, 251----1
Apr, 251----1
Mar, 251----1
Feb, 2511---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 08, 2024Jonathan ChangLeerink Partners$2.00$0.58244.83%6566.67%
Jun 07, 2022Matthew BarcusChardan Capital$4.00$1.98102.02%13233.33%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 17, 2022Chardan CapitalBuyBuyhold
Jun 07, 2022B. Riley SecuritiesBuyBuyhold

Financial Forecast

EPS Forecast

$-45 $-36 $-27 $-18 $-9 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.89$-15.85----
Avg Forecast$-40.80$-15.20$-9.20$-11.40$-11.20$-10.60
High Forecast$-38.95$-15.20$-9.20$-11.40$-11.20$-10.60
Low Forecast$-42.65$-15.20$-9.20$-11.40$-11.20$-10.60
Surprise %-95.37%4.28%----

Revenue Forecast

$0 $4M $8M $12M $16M $20M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$17.57M$220.00K$4.14M$17.45M
High Forecast--$17.57M$220.00K$4.14M$17.45M
Low Forecast--$17.57M$220.00K$4.14M$17.45M
Surprise %------

Net Income Forecast

$-950M $-760M $-570M $-380M $-190M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-40.16M$-30.07M----
Avg Forecast$-868.84M$-323.68M$-195.91M$-242.76M$-238.50M$-225.73M
High Forecast$-829.54M$-323.68M$-195.91M$-242.76M$-238.50M$-225.73M
Low Forecast$-908.13M$-323.68M$-195.91M$-242.76M$-238.50M$-225.73M
Surprise %-95.38%-90.71%----

VINC Forecast FAQ

Is Vincerx Pharma stock a buy?

Vincerx Pharma stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 7 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Vincerx Pharma is a favorable investment for most analysts.

What is Vincerx Pharma's price target?

Vincerx Pharma's price target, set by 7 Wall Street analysts, averages $3 over the next 12 months. The price target range spans from $2 at the low end to $4 at the high end, suggesting a potential 9900.00% change from the previous closing price of $0.03.

How does Vincerx Pharma stock forecast compare to its benchmarks?

Vincerx Pharma's stock forecast shows a 9900.00% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Vincerx Pharma over the past three months?

  • June 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 100.00% Strong Buy, 0% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Vincerx Pharma’s EPS forecast?

Vincerx Pharma's average annual EPS forecast for its fiscal year ending in December 2025 is $-9.2, marking a -41.96% decrease from the reported $-15.85 in 2024. Estimates for the following years are $-11.4 in 2026, $-11.2 in 2027, and $-10.6 in 2028.

What is Vincerx Pharma’s revenue forecast?

Vincerx Pharma's average annual revenue forecast for its fiscal year ending in December 2025 is $17.57M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $220K, followed by $4.14M for 2027, and $17.45M for 2028.

What is Vincerx Pharma’s net income forecast?

Vincerx Pharma's net income forecast for the fiscal year ending in December 2025 stands at $-196M, representing an 551.44% increase from the reported $-30.074M in 2024. Projections indicate $-243M in 2026, $-239M in 2027, and $-226M in 2028.